Skip to main content
Premium Trial:

Request an Annual Quote

Magnolia Medical Technologies Blood Collection Kit

Magnolia Medical Technologies launched a blood collection kit that combines the company's Steripath Gen2 Initial Specimen Diversion Device with other required supplies for the virtually contamination-free collection of blood culture samples. The kit was developed in partnership with Aero-Med, a division of Cardinal Health. Magnolia is guaranteeing a sustained reduction in blood culture contamination of 50 percent or more for all Steripath Gen2 products, and when used with the new blood culture kit and the 50 percent reduction has been surpassed, the company guarantees a .5 percent contamination rate. Magnolia is backing its claim with a $1,000 credit for any contaminiation event with th gurantee thresholds.